Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIB pediatric pharmacodynamic study of Zemuron for intubation and maintenance dosing
2005-002926-67Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rocuronium (2 arms), sponsored by Organon & Co. Primary endpoint: Total Zemuron dose requirement until reappearance of T3. Started Nov 2005; status: completed.
02
Drugs
rocuronium
Beyond the preview
Go deeper on 2005-002926-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002926-67.